Back to Search Start Over

p53 regulates CD46 expression and measles virus infection in myeloma cells

Authors :
Marion Eveillard
Steven Le Gouill
Laurent Maillet
Catherine Godon
Sophie Barillé-Nion
Marc Grégoire
Martine Amiot
Astrid Vabret
David Chiron
Frédéric Tangy
Jean-François Fonteneau
Philippe Moreau
Benoit Tessoulin
Yannick Le Bris
Anne Lok
Catherine Pellat-Deceunynck
Celine Bellanger
Géraldine Descamps
Agnès Moreau-Aubry
Service d'Hématologie Clinique [CHU Nantes] (Unité d'Investigation Clinique)
Centre hospitalier universitaire de Nantes (CHU Nantes)
Regulation of Bcl2 and p53 Networks in Multiple Myeloma and Mantle Cell Lymphoma (CRCINA-ÉQUIPE 10)
Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE)
Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE)
Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)
Laboratoire d'Hematologie [CHU de Nantes]
Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)
Service de Virologie [CHU Caen]
CHU Caen
Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)
Stress Adaptation and Tumor Escape in Breast Cancer (CRCINA-ÉQUIPE 8)
Immunogenic Cell Death and Mesothelioma Therapy (CRCINA-ÉQUIPE 4)
Integrative Oncogenomics of Multiple Myeloma Pathogenesis and Progression (CRCINA-ÉQUIPE 11)
Génomique virale et vaccination
Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris]
Ligue Régionale Contre le Cancer
DHU Oncogreffe
Actions Cancer 44
L'HémaNexT (i-site NexT)
SIRIC ILIAD (INCa-DGOS-Inserm_12558)
Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)
Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)
Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)
ANR-16-IDEX-0007,NExT (I-SITE),NExT (I-SITE)(2016)
Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)
Bernardo, Elizabeth
Source :
Blood Advances, Blood Advances, The American Society of Hematology, 2018, 2 (23), pp.3492-3505. ⟨10.1182/bloodadvances.2018025106⟩, Blood Advances, 2018, 2 (23), pp.3492-3505. ⟨10.1182/bloodadvances.2018025106⟩
Publication Year :
2018
Publisher :
American Society of Hematology, 2018.

Abstract

In this study, we assessed the sensitivity of myeloma cells to the oncolytic measles virus (MV) in relation to p53 using 37 cell lines and 23 primary samples. We showed that infection and cell death were correlated with CD46 expression, which was associated with TP53 status; TP53abn cell lines highly expressed CD46 and were preferentially infected by MV when compared with the TP53wt cell lines (P = .046 and P = .045, respectively). Infection of myeloma cells was fully dependent on CD46 expression in both cell lines and primary cells. In the TP53wt cell lines, but not the TP53abn cell lines, activation of the p53 pathway with nutlin3a inhibited both CD46 expression and MV infection, while TP53 silencing reciprocally increased CD46 expression and MV infection. We showed using a p53 chromatin immunoprecipitation assay and microRNA assessment that CD46 gene expression was directly and indirectly regulated by p53. Primary myeloma cells overexpressed CD46 as compared with normal cells and were highly infected and killed by MV. CD46 expression and MV infection were inhibited by nutlin3a in primary p53-competent myeloma cells, but not in p53-deficient myeloma cells, and the latter were highly sensitive to MV infection. In summary, myeloma cells were highly sensitive to MV and infection inhibition by the p53 pathway was abrogated in p53-deficient myeloma cells. These results argue for an MV-based clinical trial for patients with p53 deficiency.

Details

ISSN :
24739537 and 24739529
Volume :
2
Database :
OpenAIRE
Journal :
Blood Advances
Accession number :
edsair.doi.dedup.....451625fccd5cc3411a16200bc2fa32f8